ロード中...
Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression
Hydrogen sulfide-releasing aspirin (HS-ASA) is a novel compound with potential against cancer. It inhibited the growth of Jurkat T-leukemia cells with an IC(50) of 1.9 ± 0.2 µM whereas that of ASA was >5000 µM. It dose-dependently inhibited proliferation and induced apoptosis in these cells, caus...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769470/ https://ncbi.nlm.nih.gov/pubmed/23896061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2013.07.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|